We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.2B
AUM Growth
+$370M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$92.7M
2
FRC
First Republic Bank
FRC
+$73.7M
3
BP icon
BP
BP
+$67.2M
4
KHC icon
Kraft Heinz
KHC
+$62.4M
5
HUM icon
Humana
HUM
+$56.3M

Top Sells

Rank Stock Value
1
EIX icon
Edison International
EIX
+$74.9M
2
LSI
Life Storage, Inc.
LSI
+$70.7M
3
BKU icon
Bankunited
BKU
+$62.6M
4
AWK icon
American Water Works
AWK
+$61.4M
5
SCG
Scana
SCG
+$57.7M

Sector Composition

Rank Sector Weight
1 Financials 16.41%
2 Industrials 15.8%
3 Healthcare 10.6%
4 Technology 10.4%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONCE
276
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.2M 0.01%
+23,337
New +$1.68M
CLVS
277
DELISTED
Clovis Oncology, Inc.
CLVS
$1.14M 0.01%
16,747
+14,208
+560% +$993K
EXEL icon
278
Exelixis
EXEL
$13.7B
$1.11M 0.01%
+36,522
New +$971K
UPW icon
279
ProShares Ultra Utilities
UPW
$13.2M
$1.05M 0.01%
+88,860
New +$1.12M
UTHR icon
280
United Therapeutics
UTHR
$21.6B
$1.04M 0.01%
+7,018
New +$892K
VNDA icon
281
Vanda Pharmaceuticals
VNDA
$305M
$1.03M 0.01%
+67,813
New +$1.01M
ENTA icon
282
Enanta Pharmaceuticals
ENTA
$371M
$1.03M 0.01%
+17,531
New +$878K
MNTA
283
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.01M 0.01%
+72,547
New +$981K
NKTR icon
284
Nektar Therapeutics
NKTR
$2.3B
$1.01M 0.01%
+1,126
New +$666K
CELG
285
DELISTED
Celgene Corp
CELG
$1M 0.01%
9,629
+8,805
+1,069% +$994K
TSRO
286
DELISTED
TESARO, Inc.
TSRO
$996K 0.01%
+12,023
New +$1.18M
ACAD icon
287
Acadia Pharmaceuticals
ACAD
$4.65B
$993K 0.01%
+32,970
New +$1.05M
ACOR
288
DELISTED
Acorda Therapeutics
ACOR
$991K 0.01%
+385
New +$1.09M
SGEN
289
DELISTED
Seagen Inc. Common Stock
SGEN
$990K 0.01%
+18,503
New +$1.08M
HALO icon
290
Halozyme
HALO
$12.1B
$981K 0.01%
+48,401
New +$890K
LGND icon
291
Ligand Pharmaceuticals
LGND
$5.51B
$981K 0.01%
+11,479
New +$995K
KERX
292
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$980K 0.01%
+210,666
New +$1.16M
BIVV
293
DELISTED
Bioverativ Inc. Common Stock
BIVV
$980K 0.01%
+18,171
New +$994K
TBPH icon
294
Theravance Biopharma
TBPH
$884M
$974K 0.01%
+34,929
New +$1.03M
OMER icon
295
Omeros
OMER
$1.23B
$973K 0.01%
+50,065
New +$939K
MDCO
296
DELISTED
Medicines Co
MDCO
$963K 0.01%
+35,217
New +$1.08M
BMRN icon
297
BioMarin Pharmaceuticals
BMRN
$12.6B
$960K 0.01%
+10,766
New +$936K
INCY icon
298
Incyte
INCY
$24.4B
$956K 0.01%
+10,089
New +$1.05M
PBYI icon
299
Puma Biotechnology
PBYI
$476M
$955K 0.01%
+9,661
New +$1.08M
DVAX
300
DELISTED
Dynavax Technologies
DVAX
$949K 0.01%
+50,726
New +$1.02M
10 11
12
13 14

Similar funds

VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
CGI
Calixto Global Investors Coral Gables, Florida $30.7M AUM 111.27% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
CIA
Compass Investment Advisers Portland, Oregon $34.4M AUM
SL
Stevard LLC Chicago, Illinois $26.8M AUM 42.43% 1-Year Est. Return
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
MFAM
M Financial Asset Management Portland, Oregon $20.6M AUM 4.99% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Virtus Fund Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus Fund Advisers held 622 positions worth $10.2B, up 3.8% from $9.81B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus Fund Advisers's Q4 2017 filing shows 136 new, 89 increased, 249 reduced and 24 closed positions. Its largest new stake was BP: 1,855,977 shares worth $71.4M. The largest sale was Edison International, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Virtus Fund Advisers's largest Q4 2017 buy was BP: 1,855,977 shares worth $71.4M.
  • Virtus Fund Advisers added most to Republic Services in Q4 2017, an estimated $92.7M increase.
  • Virtus Fund Advisers's biggest Q4 2017 reduction was Public Storage, cutting an estimated $53.8M.
  • Virtus Fund Advisers fully exited Edison International in Q4 2017, selling an estimated $74.9M.
  • Virtus Fund Advisers's ten largest holdings make up 14% of its $10.2B portfolio in Q4 2017.
  • Virtus Fund Advisers opened 136 new positions and closed 24 in Q4 2017.
  • Virtus Fund Advisers's portfolio value rose 3.8% quarter-over-quarter to $10.2B.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.